Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.